Sean Su, MD
Family Medicine · Las Vegas, NVNPI 1760597405
Payments from drug & device makers
Across 128 payments — averaging $8844.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.1M
- AstraZeneca$974
- AbbVie$560
- Amgen$466
- GSK$450
- Solta Medical, A Division Of Bausch Health US, LLC$401
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,087100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 55 | $1,126,193 |
| AstraZeneca | 10 | $974 |
| AbbVie(2 entities) | 9 | $560 |
| Amgen | 4 | $466 |
| GSK | 4 | $450 |
| Solta Medical, A Division Of Bausch Health US, LLC | 5 | $401 |
| Genentech USA, Inc. | 2 | $267 |
| Sanofi | 2 | $240 |
| Abbott | 2 | $227 |
| Harmony Biosciences LLC | 2 | $199 |
| Novo Nordisk | 2 | $151 |
| Amarin Pharma, Inc. | 2 | $151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $141 |
| Revance Therapeutics, Inc. | 2 | $129 |
| Theratechnologies Inc. | 1 | $125 |
| United Therapeutics Corporation | 1 | $121 |
| Shire North American Group Inc | 1 | $121 |
| Zimmer Biomet | 1 | $121 |
| Merz North America, Inc. | 2 | $118 |
| Redhill Biopharma Inc. | 1 | $117 |
| Johnson & Johnson | 1 | $116 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Actelion Pharmaceuticals US, Inc. | 1 | $111 |
| Sunovion Pharmaceuticals Inc. | 1 | $108 |
| Lilly USA, LLC | 2 | $90 |
| Boehringer Ingelheim | 1 | $83 |
| Exact Sciences | 3 | $56 |
| Gilead | 2 | $48 |
| Mckesson Medical-surgical, Inc. | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Novartis | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,132,118 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $11,211 |
| Humulin 70-30Insulin Nph Hum/Reg Insulin Hm | 27 | $5,298 |
| Humulin NInsulin Nph Human Isophane | 18 | $1,487 |
| Atorvastatin Calcium | 208 | $1,482 |
| Levothyroxine Sodium | 112 | $1,068 |
| Insulin SyringeSyringe-Needle,insulin,0.5 Ml | 15 | $946 |
| Metoprolol Succinate | 29 | $548 |
| Losartan Potassium | 83 | $450 |
| Amlodipine Besylate | 118 | $406 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $382 |
| Lisinopril | 93 | $298 |
| Montelukast Sodium | 20 | $260 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 34 | $257 |
| Metformin Hcl | 90 | $169 |
| Rosuvastatin Calcium | 18 | $161 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,126,193 | $11,21117 claims |
| Lilly USA, LLCHumulin 70-30, Humulin N | $90 | $6,78545 claims |
| AbbVieSynthroid | $560 | $5412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Las Vegas
- Rogelio MachucaLas Vegas$3.3M
- Maxine InghamLas Vegas$2.9M
- Elliot ShinLas Vegas$2.1M
- Robert KaplanLas Vegas$1.7M
- Naz WahabLas Vegas$735K
- Carmelo RilleraLas Vegas$531K
- Peter PhilanderLas Vegas$524K
- Jerry CadeLas Vegas$381K
- Dana ForteLas Vegas$169K
- Francisco MachucaLas Vegas$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.